High HIF-1α expression genotypes increase odds ratio of oral cancer

Head and Neck Oncology

Volumn 4, Issue 5, 2012, Pages

  Alves, L R ^a   Fraga, C A C ^a   Oliveira, M V M ^a   Sousa, A A ^a   Jorge, A S B ^a   Marques Silva, L ^a   Santos, S H S ^a,b   Jones, K M ^a   De Paula, A M B ^a   Guimaraes A L S ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; EPITHELIUM DYSPLASIA; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; HYPOXIA INDUCIBLE FACTOR 1ALPHA GENE; MAJOR CLINICAL STUDY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR GENE; TUMOR VOLUME;

EID: 84872727706     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Scully C, Porter S. Oral cancer. West J Med. 2001 May;174(5):348-51. (Pubitemid 32463693)
2. Argiris A, Eng C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res. 2003;114:15-60.
3. Pindborg JJ. Clinical relevance of precancerous lesions of oral mucosa. Recent Results Cancer Res. 1994;134:9-16.
4. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215.
5. Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, Martin ID, Herraez B, Gamallo C. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol. 2009 Aug;16(8):2351-8.
6. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. Advances in the biology of oral cancer. Oral Oncol. 2007 Jul;43(6):523-34. (Pubitemid 46860349)
7. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basichelix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995 Jun;92(12):5510-4.
8. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997 Sep;272(36):22642-7.
9. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001 Jun;11(3):293-9. (Pubitemid 32480296)
10. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J Interferon Cytokine Res. 2005 Jun;25(6):297-310. (Pubitemid 40911381)
11. Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression by HIF-1. Novartis Found Symp. 2006;272:2-8.
12. Nava-Salazar S, Sanchez-Rodriguez EN, Mendoza-Rodriguez CA, Moran C, Romero-Arauz JF, Cerbon MA. Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study. BMC Res Notes. 2011 Mar;4:68.
13. Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS, et al. A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol. 2012 Feb;48(2):130-5.
14. Tilakaratne WM, Nissanka-Jayasuriya EH. Value of HIF-1alpha as an independent prognostic indicator in oral squamous cell carcinoma. Expert Rev Mol Diagn. 2011 Mar;11(2):145-7.
15. Fonseca-Silva T, Farias LC, Cardoso CM, Souza LR, Carvalho Fraga CA, Oliveira MV, et al. Analysis of p16(CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia. Pathobiology. 2012;79(2):94-100.
16. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA. 2003 Jan;100(1):177-82. (Pubitemid 36078048)
17. Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003 Jan;21(1):3-7. (Pubitemid 37127467)
18. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. 2005.
19. Bryne M. Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: A review. J Oral Pathol Med. 1991 Oct;20(9): 413-20.
20. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992 Apr;166(4):375-81.
21. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495-503. (Pubitemid 20078123)
22. Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, et al. Effect of age on the association between p16CDKN2A methylation and DNMT3B polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010 Jul;37(1):167-76.
23. Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, Dos Santos EP, Silva TF, et al. Association of -308 TNFalpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol. 2011 Sep;47(9):888-94.
24. Fraga CA, Oliveira MV, Domingos PL, Botelho AC, Guimaraes AL, Teixeira-Carvalho A, et al. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance. Appl Immunohistochem Mol Morphol. 2012 May;20(3):285-90.
25. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990 Mar;69(3):325-30. (Pubitemid 20091287)
26. Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, et al. DNMT3B (C46359T) polymorphisms and immunoexpression of DNMT3b and DNMT1 proteins in oral lichen planus. Pathobiology. 2012;79(1):18-23.
27. Guimaraes AL, Correia-Silva JF, Diniz MG, Xavier GM, Horta MC, Gomez RS. Investigation of functional gene polymorphisms: IL-1B, IL-6 and TNFA in benign migratory glossitis in Brazilian individuals. J Oral Pathol Med. 2007 Oct;36(9):533-7. (Pubitemid 47393532)
28. Guimaraes AL, de Sa AR, Victoria JM, de FC-S, Gomez MV, Gomez RS. Interleukin-1beta and serotonin transporter gene polymorphisms in burning mouth syndrome patients. J Pain. 2006 Sep;7(9):654-8. (Pubitemid 44291601)
29. Guimaraes AL, Gomes CC, da Silva LM, Correia-Silva JF, Victoria JM, Gomez RS, et al. Association between oral HSV-1 and survival in allogeneic hematopoietic stem cell transplanted patients. Med Oral Patol Oral Cir Bucal. 2009 Feb;14(2):E62-8.
30. Guimaraes AL, Perdigao PF, Siqueira FM, Castro WH, Gomez RS. Oral metastasis of breast carcinoma diagnosed by fine needle aspiration cytology. A case report. Acta Cytol. 2003 Nov-Dec;47(6):1074-6. (Pubitemid 37475065)
31. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, et al. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther. 2005 Nov;4(11):1222-5.
32. Chen MK, Chiou HL, Su SC, Chung TT, Tseng HC, Tsai HT, et al. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol. 2009 Dec;45(12):e222-6.
33. Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M, Tamakawa S, Yoshie M, et al. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 2006 Dec;66(23):11263-70. (Pubitemid 46009955)
34. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, et al. Hypoxiainducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol. 2003 Jun;162(6):1789-806. (Pubitemid 36613038)
35. Griffiths EA, Pritchard SA, Valentine HR, Whitchelo N, Bishop PW, Ebert MP, et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 2007 Jan;96(1):95-103. (Pubitemid 46094645)
36. Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U, Kirkpatrick CJ. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer. 2008 Nov;8:320.
37. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 2000 Nov;60(21):6189-95.
38. Yao DF, Jiang H, Yao M, Li YM, Gu WJ, Shen YC, et al. Quantitative analysis of hepatic hypoxia-inducible factor-1 alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2009 Aug;8(4):407-13.
39. Zhong H, Semenza GL, Simons JW, De Marzo AM. Up-regulation of hypoxiainducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev. 2004;28(2):88-93. (Pubitemid 38448745)
40. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001 Feb;93(4):309-14. (Pubitemid 32219818)
41. Horree N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP. Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol. 2007;29(3):219-27. (Pubitemid 46855701)
42. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1104-17. (Pubitemid 34215137)
43. Xiao Z, Liu Q, Mao F, Wu J, Lei T. TNF-alpha-Induced VEGF and MMP-9 Expression promotes hemorrhagic transformation in pituitary adenomas. Int J Mol Sci. 2011;12(6):4165-79.
44. Lee SY, Horbelt M, Mang HE, Knipe NL, Bacallao RL, Sado Y, et al. MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury. Am J Physiol Renal Physiol. 2011 Jul;301(1):F101-9.
45. Gandolfo M, Keszler A, Lanfranchi H, Itoiz ME. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Apr;111(4):486-93.
46. Raica M, Cimpean AM, Ribatti D. Angiogenesis in pre-malignant conditions. Eur J Cancer. 2009 Jul;45(11):1924-34.
47. Raica M, Mogoanta L, Cimpean AM, Alexa A, Ioanovici S, Margaritescu C, et al. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Rom J Morphol Embryol. 2008;49(1):37-42.
48. Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997 Dec;57(23): 5328-35. (Pubitemid 27516371)
49. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999 May;399(6733):271-5. (Pubitemid 29246458)
50. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001 Jun;21(12): 3995-4004. (Pubitemid 32476461)